Niraparib clinical trials poly ADP-ribose polymerase (PARP) inhibitor

MK-4827 - MK4827 - MK 4827 - niraparib hydrochloride - 2-(4-(piperidin-3-yl)phenyl)-2H-indazole-7-carboxamide

Recap Results Trial description old Pinterest treatment Z

Advanced breast cancer (metastatic)

All type of patients: 1 trials - BRAVO

BRCA-mutated: 1 trials - BRAVO

Ovarian cancer

All type of patient (BRCA mutated or not): 2 trials - ENGOT-OV16/NOVA gBRCA - ENGOT-OV16/NOVA non-gBRCA

Patients with BRCA mutation: 1 trials - ENGOT-OV16/NOVA gBRCA

Patients without BRCA mutation: 1 trials - ENGOT-OV16/NOVA non-gBRCA